Abstract
Pulmonary disease is the leading cause of hospitalizations and mortality in patients with systemic sclerosis (SSc) [1]. This chapter will discuss the management of ILD in SSc with a focus on whom to treat, how long to treat, and what pharmacological therapies to use. Previous chapters in this textbook have discussed the pathogenesis of SSc-ILD in detail.
Author supplied keywords
Cite
CITATION STYLE
APA
Khanna, D., & Tashkin, D. P. (2012). Treatment of interstitial lung disease. In Scleroderma: From Pathogenesis to Comprehensive Management (pp. 421–427). Springer US. https://doi.org/10.1007/978-1-4419-5774-0_35
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free